Under way, not recruiting
Real World Registry for Use of the Ion Endoluminal System
NCT06004440 · Intuitive Surgical · Updated 24 April 2026
- What is being tested
- Ion Endoluminal System
- For
- Lung Cancer; Multiple Pulmonary Nodules; Lung Neoplasms; Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Neoplasms; Lung Diseases; Respiratory Tract Diseases
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 1,301 people. The full rules are on the registry page.
- Where
- United States (16 sites)
- When
- Starts or started 21 Sept 2023, ends Aug 2028. Registered 22 Aug 2023.
- Results
- None posted yet.
In the researchers' words
The primary objective of this study is to evaluate the performance of the Ion Endoluminal System with real-world use for pulmonary lesion localization or biopsy.
Sites
- Orlando Health Orlando Regional Medical CenterOrlando, Florida, United States
- Ascension Alexian BrothersElk Grove Village, Illinois, United States
- Blessing HospitalQuincy, Illinois, United States
- Kansas University Medical CenterKansas City, Kansas, United States
- Tulane UniversityNew Orleans, Louisiana, United States
- Henry Ford HospitalDetroit, Michigan, United States
- Mayo ClinicRochester, Minnesota, United States
- Mercy Hospital of BuffaloBuffalo, New York, United States
- Atrium Health of the CarolinasCharlotte, North Carolina, United States
- Cone Health Moses Cone Memorial HospitalGreensboro, North Carolina, United States
- FirstHealth Moore Regional HospitalPinehurst, North Carolina, United States
- Ohio State University Wexner Medical CenterColumbus, Ohio, United States
- Centennial Medical CenterNashville, Tennessee, United States
- Methodist HospitalSan Antonio, Texas, United States
- Intermountain Medical CenterMurray, Utah, United States
- Aurora Medical Center KenoshaKenosha, Wisconsin, United States